Loading clinical trials...

Via, a Hyaluronic Acid (HLA) Based Vaginal Moisturizer Study | Clinical Trials | Clareo Health

NOT_YET_RECRUITINGNA

Via, a Hyaluronic Acid (HLA) Based Vaginal Moisturizer Study

A Randomized Controlled Trial Comparing the Efficacy of Topical Vaginal Estrogen Versus Topical Vaginal Estrogen Plus Via, a Hyaluronic Acid-Based Vaginal Moisturizer, in the Treatment of Genitourinary Syndrome of Menopause

NCT07038070•NYU Langone Health

View on ClinicalTrials.gov

Summary

This study aims to evaluate whether the administration of vaginal estrogen along with Via, a hyaluronic acid-based vaginal moisturizer, offers superior relief from symptoms of genitourinary syndrome of menopause (GSM) in the urogynecologic patient population, compared to administration of vaginal estrogen alone.

Eligibility

Age

45 - No limit years

Sex

FEMALE

Healthy Volunteers

Inclusion Criteria

•Postmenopausal (last menstrual period at least 12 months ago).
•Aged 45 years or older and have symptoms of Genitourinary Syndrome of Menopause (GSM).
•Have never tried vaginal estrogen therapy, or have tried vaginal estrogen therapy, but have not used vaginal estrogen and/or hyaluronic acid products for management of GSM symptoms within the last 3 months.
•Capable of signing informed consent.
•Capable and willing to follow all study-relation visits.

Exclusion Criteria

•Subjects currently diagnosed with or undergoing treatment for hormone-sensitive disease (e.g. breast cancer)
•Subjects currently using systemic hormone replacement therapy
•Subjects currently using estrogen hormonal therapies or hormone modulators (aromatase inhibitors or selective estrogen receptor modulators)

Locations (1)

NYU Langone Health

New York, New York, United States

Key Dates

Start Date

July 1, 2025

Primary Completion Date

May 1, 2026

Completion Date

May 1, 2026

Last Updated

June 26, 2025

Enrollment

196

ESTIMATED participants

Conditions

Genitourinary Syndrome of Menopause (GSM)

Interventions

Vaginal estrogen tablet

DRUG

Via Solv Wellness (Hyaluronic Acid Therapy)

DEVICE

Contacts

Benjamin Brucker

CONTACT

917-520-1848 Benjamin.brucker@nyulangone.org

Nadege Assassi

CONTACT

732-668-8160 nadege.assassi@nyulangone.org

A Randomized, Single Center Pilot Study Comparing Hyaluronic Acid to Vaginal Estrogen for Treatment of Genitourinary Syndrome of Menopause

NCT04544475

Genitourinary Syndrome of Menopause (GSM)

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 26, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions